Perioperative assessment of the remnant liver functional capacity with the 13C methacetin breath test

Not Applicable

• Conditions: iver resection of 3 or more liver segments (according to Couinaud classification) and its effect on liver functional capacity; C22; Malignant neoplasm of other and unspecified parts of biliary tract; C78.7; C24; D37.6; Malignant neoplasm of liver and intrahepatic bile ducts; D13.4; Secondary malignant neoplasm of liver and intrahepatic bile duct; Liver, gallbladder and bile ducts

• Registration Number: DRKS00016795
• Lead Sponsor: Allgemein- und Viszeralchirurgie Asklepios Klinik Barmbek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-21
• Study Completion: 2020-02-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All adult patients (> 18 years of age) able to give consent, who will undergo a liver resection of 3 or more liver segments according to Couinaud classification at the Department of General and Visceral Surgery of the Asklepios Klinik Barmbek within one year of the study beginning.

Exclusion Criteria

1. Patients with an allergy to acetaminophen or methacetin.

2. Patients who have received a strong CYP1A2 agonist (e.g., ciprofloxacin, fluvoxamine, enoxacin, verapamil) within the half-life of these substances

Study & Design

• Study Type: interventional
• Study Design: Not specified